US Patent 8987473 Ring-fused compound

Patent 8987473 was granted and assigned to Sato Pharmaceutical on March, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Sato Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89874730

Patent Inventor Names

Shinichi Fujioka0

Yoshiki Itoh0

Eri Kondoh0

Hirobumi Takahashi0

Keita Nagai0

Kenichi Tanaka0

Koh Nagasawa0

Motoaki Baba0

Date of Patent

March 24, 2015

Patent Application Number

139822000

Date Filed

January 30, 2012

Patent Citations Received

Patent Primary Examiner

‌

Niloofar Rahmani

Patent abstract

The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below.